Premium Nahrungsergänzungsmittel | artgerecht

DeSanctis-Cacchione Syndrome – Causes and Treatment

DeSanctis-Cacchione Syndrome is an extremely rare genetic disorder combining severe UV light sensitivity, progressive neurological deterioration, and developmental delays.

Regular tips about health Regular tips about health

Things worth knowing about "DeSanctis-Cacchione Syndrome"

DeSanctis-Cacchione Syndrome is an extremely rare genetic disorder combining severe UV light sensitivity, progressive neurological deterioration, and developmental delays.

What is DeSanctis-Cacchione Syndrome?

DeSanctis-Cacchione Syndrome is an extremely rare, autosomal recessive genetic disorder. It represents one of the most severe forms of Xeroderma Pigmentosum (XP), a condition in which the cellular ability to repair UV-induced DNA damage is severely impaired or completely absent. In addition to the classic skin manifestations of Xeroderma Pigmentosum, DeSanctis-Cacchione Syndrome is characterised by significant neurological deterioration and developmental abnormalities. The syndrome was first described in 1932 by Italian physicians Carlo De Sanctis and Aldo Cacchione.

Causes and Genetics

The underlying cause of DeSanctis-Cacchione Syndrome is a mutation in genes involved in Nucleotide Excision Repair (NER), a cellular mechanism responsible for correcting UV-induced DNA damage. The genes most commonly affected belong to the XP complementation groups, particularly XPA and XPD (ERCC2). When these repair mechanisms fail, DNA damage accumulates in skin and nerve cells, leading to the characteristic features of the syndrome.

Inheritance pattern: autosomal recessive (both parents must carry one defective gene copy)
Most frequently affected genes: XPA and XPD
Estimated prevalence: fewer than 1 in 1,000,000 individuals

Symptoms

DeSanctis-Cacchione Syndrome presents with a distinctive combination of skin, neurological, and developmental symptoms:

Skin Symptoms

Extreme photosensitivity: even minimal UV exposure causes severe sunburn
Numerous freckles and pigmented lesions appearing in early childhood
Dry, parchment-like skin (Xeroderma)
Very high risk of skin cancer (basal cell carcinoma, squamous cell carcinoma, melanoma) even in childhood

Neurological Symptoms

Progressive neurological degeneration: ongoing loss of nerve cells
Microcephaly: abnormally small head circumference
Ataxia: impaired coordination and balance
Hyporeflexia or areflexia: diminished or absent reflexes
Sensorineural hearing loss
Spasticity and muscle weakness

Developmental Abnormalities

Intellectual disability of varying degrees
Growth retardation and short stature
Hypogonadism: reduced function of the gonads
Delayed onset of puberty

Diagnosis

The diagnosis of DeSanctis-Cacchione Syndrome is based on a combination of clinical and laboratory investigations:

Clinical examination: identification of characteristic skin and neurological findings
Molecular genetic testing: detection of mutations in NER genes (e.g., XPA, XPD)
DNA repair assays using cultured skin fibroblasts: confirmation of impaired UV-induced DNA repair
Neurological imaging (brain MRI): often reveals cerebral atrophy, demyelination, and cerebellar changes
Neurophysiological studies: electromyography (EMG), nerve conduction velocity testing
Audiological assessment to evaluate hearing loss

Treatment

There is currently no curative therapy for DeSanctis-Cacchione Syndrome. Management is symptomatic and focused on improving quality of life and preventing complications.

UV Protection

Strict and consistent protection from UV radiation is the most critical intervention: protective clothing, UV-blocking eyewear, high-factor sunscreen (SPF 50+)
Avoidance of direct sunlight, especially during peak hours
UV-protective film on windows in homes and schools

Skin Surveillance and Cancer Management

Regular dermatological check-ups for early detection of skin cancers
Surgical removal of skin tumours as required

Neurological and Supportive Therapy

Physiotherapy and occupational therapy to maintain motor function
Speech and language therapy for communication and swallowing difficulties
Early intervention programmes and special educational support for intellectual disability
Pharmacological management of spasticity and seizures

Multidisciplinary Care

Given the involvement of multiple organ systems, close collaboration among dermatologists, neurologists, paediatricians, geneticists, and therapists is essential for comprehensive care.

Prognosis

The prognosis for DeSanctis-Cacchione Syndrome is serious. Neurological deterioration typically progresses over time, and many affected individuals have a reduced life expectancy. Consistent UV protection and regular medical monitoring can reduce complications such as skin cancer and improve overall quality of life. Early diagnosis and interdisciplinary management are critical to optimising outcomes.

References

Kraemer, K. H. et al. (2007): Xeroderma pigmentosum. In: Nature Reviews Disease Primers. PMID: 17657700.
Lehmann, A. R. et al. (2011): Xeroderma pigmentosum. In: Orphanet Journal of Rare Diseases, 6:70. DOI: 10.1186/1750-1172-6-70.
OMIM (Online Mendelian Inheritance in Man): DeSanctis-Cacchione Syndrome, Entry #278800. Johns Hopkins University. Available at: https://www.omim.org/entry/278800

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.

Most read entries

3 Posts in this encyclopedia category